5min chapter

The HemOnc Pulse cover image

Discussing the Role of MRD in CLL With Talal Hilal, MD

The HemOnc Pulse

CHAPTER

Navigating the MRD Controversy in CLL

Exploring the challenges and potential benefits of minimal residual disease (MRD) detection in chronic lymphocytic leukemia (CLL), including discussions on MRD-guided trials, time-limited therapy, targeted agent doublets, and the debate between triplet and doublet therapies.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode